Logo for ImmuPharma plc

ImmuPharma Investor Relations Material

Latest events

Logo for ImmuPharma

H1 2024

9 Sep, 2024
Logo for ImmuPharma

H2 2023

5 Jun, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from ImmuPharma plc

Access all reports
ImmuPharma plc is a pharmaceutical company focused on the research, development, and commercialization of novel peptide-based drugs. The company specializes in therapies for autoimmune and inflammatory diseases, with activities spanning early-stage discovery through to clinical development. Its research is supported by collaborations with scientific institutions and licensing partnerships. The company is headquartered in London, United Kingdom, and its shares are listed on the AIM.